GlobeNewswire

Intrinsyc Technologies (TSX: ITC and OTC: ISYRF) debuts system on module and development kit powered by NXP i.MX 8M processor

Dela

Powerful Embedded Computing Solutions Optimized for Multimedia Applications

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intrinsyc Technologies Corporation (TSX:ITC) (OTC:ISYRF) ("Intrinsyc" or the "Company"), a leading provider of solutions for the development and production of embedded and Internet of Things ("IoT") products, today announced the availability of the Open-X(TM) 8M System on Module ("SOM") and Development Kit

Intrinsyc's Open-X(TM) 8M SOM incorporates the new 64-bit NXP i.MX 8M processor and is ideal for powering IoT devices ranging from consumer smart home appliances to industrial building automation products. Its ultra-compact (55mm x 35mm) size enables its use in a wide range of form factors. The feature-rich SOM, with its advanced video and audio features, is ideal for streaming video/audio devices, voice control applications, and human-machine interface solutions. It offers high quality video playback with full 4K UHD and HDR along with the highest level of pro-audio fidelity. The broad range of interfaces, including HDMI 2.0a, two USB 3.0, one PCIe, Gigabit Ethernet, and pre-certified dual-band 2x2 MU-MIMO WLAN make the SOM suitable for a wide range of embedded and IoT products. 

"We are excited to expand our portfolio of embedded SOM solutions with the newly launched NXP i.MX 8M processor," stated Cliff Morton, Vice President, Client Solutions, Intrinsyc Technologies Corporation.  "Intrinsyc's Open-X(TM) SOMs provide a flexible way to rapidly bring IoT devices to market with reduced risk; combining the time-to-market benefits of an off-the-shelf product, with the flexibility and optimization of a custom design. Our latest System on Module, the Open-X(TM) 8M, is ready for production use and will expand opportunities in a variety of multimedia capable embedded and IoT products." 

"Intrinsyc has a long history of providing exceptional product development services for embedded and IoT devices," stated Robert Thompson, i.MX Ecosystem Manager at NXP Semiconductors, N.V.  "We are pleased to see the launch of Intrinsyc's production-ready SOM and development kit powered by the i.MX 8M processor. Intrinsyc's strong product development and technical support capabilities, coupled with a production-ready i.MX 8M powered SOM will help companies rapidly develop their multimedia capable products."

Open-X(TM) 8M SOM Specifications

Processors

  • Quad-core ARM Cortex-A53 MPCore platform
    • Quad symmetric Cortex-A53 processors: 32 KB L1 Instruction Cache, 32 KB L1 Data Cache
    • Support of 64-bit ARMv8-A architecture: 1 MB unified L2 cache, Frequency of 1.5 GHz
  • ARM Cortex-M4 core platform
    • 16 KB L1 Instruction Cache, 16 KB L1 Data Cache, 256 KB tightly coupled memory (TCM)

Memory/Storage

  • 3GB LPDDR4 RAM, 16GB eMMC Flash

Wireless Module - FCC/IC pre-certified

  • WLAN 802.11a/b/g/n/ac 2.4/5.0 GHz 2x2 MU-MIMO
  • Bluetooth 4.1

Display Interfaces

  • HDMI 2.0a supporting resolution up to 4096 x 2160 at 60 Hz
  • 4-lane MIPI DSI supporting display resolution up to 1920x1080 at 60 Hz

Camera Interface

  • 2x 4-lane MIPI CSI2 camera inputs

Video

  • 4Kp60 HEVC/H.265 main, and main 10 decoder
  • 4Kp60 VP9 decoder
  • 4Kp30 AVC/H.264 decoder
  • 1080p60 MPEG-2, MPEG-4p2, VC-1, VP8, RV9, AVS, MJPEG, H.263 decoder

Graphics

  • 4 shader
  • 267 million triangles/sec
  • 1.6 Giga pixel/sec
  • 32 GFLOPs 32-bit or 64 GFLOPs 16-bit
  • Supports OpenGL ES 1.1, 2.0, 3.0, 3.1, Open CL 1.2, and Vulkan

Audio

  • S/PDIF input and output
  • 1x 16 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)
  • 1x 8 channel receive SAI digital audio interface (I2S, AC97, TDM, DSP)
  • 2x 2 channel bi-directional SAI digital audio interface (I2S, AC97, TDM, DSP)

I/O

  • 2x USB 3.0, 1x PCIe Gen2, Gigabit Ethernet, 4-bit SDIO, 2x debug UART, JTAG

OS Support

  • Linux & Android 8

Operating Environment

  • Input power: 3.3V
  • Operating Temperature: 0°C to +70°C

Additional information is available at: https://www.intrinsyc.com/imx-embedded-development-kits/open-x-8m-development-kit/

To enable rapid development of devices using the Open-X(TM) 8M SOM, Intrinsyc offers the Open-X(TM) 8M Development Kit; a full-featured development platform including the software tools and accessories required to immediately begin development. 

Intrinsyc's Open-X(TM) 8M Development Kit is a cost-effective, feature rich, multimedia-focused, exposed board platform powered by our Open-X(TM) 8M System on Module (SOM). It is ideal for evaluation of the Open-X(TM) 8M SOM as well as jump-starting development of streaming video/audio devices, voice control and general human-machine interface solutions. HDMI 2.0a video output is provided for ease of use out of the box, and our optional LCD/touchpanel is also compatible. With a multitude of high performance interconnect options, including two USB3.0 ports, Gigabit Ethernet, PCIe Gen2, and pre-certified dual-band 2x2 MU-MIMO WLAN, this platform is ideal for development of a wide range of multimedia capable embedded and IoT applications.  

In support of new product designs based on the Open-X(TM) 8M SOM, Intrinsyc offers a robust board support package, advanced technical support and comprehensive product development services including; rapid prototyping, mechanical and electrical design, BSP and driver development, and middleware and application development.  Contact Intrinsyc at sales@Intrinsyc.com with your product requirements and have one of the Company's solution architects help plan for your successful product development and launch.

Intrinsyc will showcase the Open-X(TM) 8M SOM and Development Kit at Embedded World 2018, Nuremberg Exhibition Centre Booth 4A-425, Nuremberg, Germany, from 27 February to 1 March.

About Intrinsyc Technologies Corporation
Intrinsyc Technologies Corporation is a product development company that provides hardware, software, and engineering and production services that enable rapid commercialization of embedded and Internet of Things (IoT) products. Solutions span the development life cycle from concept to production and help device makers and technology suppliers create compelling differentiated products with faster time-to-market.  Intrinsyc's Open-Q(TM) and Open-X(TM) System on Modules incorporate the industry's most advanced processor technology and help OEMs to rapidly bring industry leading products, with rich functionality and high performance, to market. Intrinsyc is publicly traded (TSX:ITC) (OTC:ISYRF) and is headquartered in Vancouver, BC, Canada.

For more information, please contact:

Rachele Webb
Senior Marketing Communications Coordinator
Intrinsyc Technologies Corporation
Email: rwebb@intrinsyc.com

Intrinsyc, Open-X and their respective logos are trademarks, registered and otherwise, of Intrinsyc Technologies Corporation in Canada, European Union, Taiwan, United States of America and other jurisdictions




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Intrinsyc Technologies Corporation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum